|
1
|
Sakai A, Nishida S, Okimoto N, Okazaki Y,
Hirano T, Norimura T, Suda T and Nakamura T: Bone marrow cell
development and trabecular bone dynamics after ovariectomy in ddy
mice. Bone. 23:443–451. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Melton LJ 3rd, Chrischilles EA, Cooper C,
Lane AW and Riggs BL: How many women have osteoporosis? JBMR
Anniversary Classic JBMR, Volume 7, Number 9, 1992. J Bone Miner
Res. 20:886–892. 2005.PubMed/NCBI
|
|
3
|
Rodan GA and Martin TJ: Therapeutic
approaches to bone diseases. Science. 289:1508–1514. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gowen M, Emery JG and Kumar S: Emerging
therapies for osteoporosis. Expert Opin Emerg Drugs. 5:1–43. 2000.
View Article : Google Scholar
|
|
5
|
Endo I and Matsumoto T: New approved drugs
for osteoporosis in Japan. Clin Calcium. 22:870–876.
2012.PubMed/NCBI
|
|
6
|
Lakatos P: Pharmacologic treatment of
osteoporosis - 2011. Orv Hetil. 152:1320–1326. 2011.(In
Hungarian).
|
|
7
|
Kalu DN: The ovariectomized rat model of
postmenopausal bone loss. Bone Miner. 15:175–191. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
US Food and Drug Administration.
Guidelines for preclinical and clinical evaluation of agents used
in the prevention or treatment of postmenopausal osteoporosis.
Rockville, MD, USA: pp. 2–22. 1994
|
|
9
|
Heaney RP, Recker RR, Watson P and Lappe
JM: Phosphate and carbonate salts of calcium support robust bone
building in osteoporosis. Am J Clin Nutr. 92:101–105. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Aloia JF, Vaswani A, Yeh JK, Ross PL,
Flaster E and Dilmanian FA: Calcium supplementation with and
without hormone replacement therapy to prevent postmenopausal bone
loss. Ann Intern Med. 120:97–103. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Han SY, Lee JR, Kwon YK, Jo MJ, Park SJ,
Kim SC, Lee HS and Ku SK: Ostreae Testa prevent ovariectomy-induced
bone loss in mice by osteoblast activations. J Ethnopharmacol.
114:400–405. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pak CY, Poindexter J and Finlayson B: A
model system for assessing physicochemical factors affecting
calcium absorbability from the intestinal tract. J Bone Miner Res.
4:119–127. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Whiting SJ and Pluhator MM: Comparison of
in vitro and in vivo tests for determination of availability of
calcium from calcium carbonate tablets. J Am Coll Nutr. 11:553–560.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Seo HP, Kim JM, Shin HD, Kim TK, Chang HJ,
Park BR and Lee JW: Production of −1,3/1,6-glucan by
Aureobasidium pullulans SM-2001. Kor J Biotechnol Bioeng.
17:376–380. 2002.
|
|
15
|
Shin HD, Yang KJ, Park BR, Son CW, Jang HJ
and Ku SK: Antiosteoporotic effect of Polycan, beta-glucan from
Aureobasidium, in ovariectomized osteoporotic mice.
Nutrition. 23:853–860. 2007. View Article : Google Scholar
|
|
16
|
Lee HS, Cho HR, Moon SB, Shin HD, Yang KJ,
Park BR, Jang HJ, Kim LS and Ku SK: Effect of β-glucan from
Aureobasidium pullulans on rat rib fracture healing. Lab
Anim Res. 24:39–44. 2008.
|
|
17
|
Kim HD, Cho HR, Moon SB, Shin HD, Yang KJ,
Park BR, Jang HJ, Kim LS, Lee HS and Ku SK: Effect of exopolymers
from Aureobasidium pullulans on formalin-induced chronic paw
inflammation in mice. J Microbiol Biotechnol. 16:1954–1960.
2006.
|
|
18
|
Harris ST, Watts NB, Genant HK, McKeever
CD, Hangartner T, Keller M, Chesnut CH 3rd, Brown J, Eriksen EF,
Hoseyni MS, Axelrod DW and Miller PD: Effects of risedronate
treatment on vertebral and nonvertebral fractures in women with
postmenopausal osteoporosis: a randomized controlled trial.
Vertebral Efficacy With Risedronate Therapy (VERT) Study Group.
JAMA. 282:1344–1352. 1999. View Article : Google Scholar
|
|
19
|
World Health Organization Regional Office
for the Western Pacific, . Research Guidelines for Evaluating the
Safety and Efficacy of Herbal Medicines. WHO Regional Publications;
pp. 5–34. 1993
|
|
20
|
Parfitt AM, Drezner MK, Glorieux FH, Kanis
JA, Malluche H, Meunier PJ, Ott SM and Recker RR: Bone
histomorphometry: standardization of nomenclature, symbols, and
units. Report of the ASBMR Histomorphometry Nomenclature Committee.
J Bone Miner Res. 2:595–610. 1987. View Article : Google Scholar
|
|
21
|
Manolagas SC, Kousteni S and Jilka RL: Sex
steroids and bone. Recent Prog Horm Res. 57:385–409. 2002.
View Article : Google Scholar
|
|
22
|
Lorden JF and Caudle A: Behavioral and
endocrinological effects of single injections of monosodium
glutamate in the mouse. Neurobehav Toxicol Teratol. 8:509–519.
1986.PubMed/NCBI
|
|
23
|
Yamamoto M, Fisher JE, Gentile M, Seedor
JG, Leu CT, Rodan SB and Rodan GA: The integrin ligand echistatin
prevents bone loss in ovariectomized mice and rats. Endocrinology.
139:1411–1419. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xie F, Wu CF, Zhang Y, Yao XS, Cheung PY,
Chan AS and Wong MS: Increase in bone mass and bone strength by
Sambucus williamsii HANCE in ovariectomized rats. Biol Pharm
Bull. 28:1879–1885. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ke HZ, Foley GL, Simmons HA, Shen V and
Thompson DD: Long-term treatment of lasofoxifene preserves bone
mass and bone strength and does not adversely affect the uterus in
ovariectomized rats. Endocrinology. 145:1996–2005. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ederveen AG and Kloosterboer HJ: Tibolone,
a steroid with a tissue-specific hormonal profile, completely
prevents ovariectomy-induced bone loss in sexually mature rats. J
Bone Miner Res. 14:1963–1970. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Blanqué R, Cottereaux C and Gardner CR:
Phasic production of urinary pyridinium crosslinks in mice: the
effect of ovariectomy. Calcif Tissue Int. 68:102–108.
2001.PubMed/NCBI
|
|
28
|
Tanaka S, Shimizu M, Debari K, Furuya R,
Kawawa T and Sasaki T: Acute effects of ovariectomy on wound
healing of alveolar bone after maxillary molar extraction in aged
rats. Anat Rec. 262:203–212. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Syed Z and Khan A: Bone densitometry:
applications and limitations. J Obstet Gynaecol Can. 24:476–484.
2002.PubMed/NCBI
|
|
30
|
Diez F: Guidelines for the diagnosis of
osteoporosis by densitometric methods. J Manipulative Physiol Ther.
25:403–415. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yamaguchi K, Yada M, Tsuji T, Kuramoto M
and Uemura D: Suppressive effect of norzoanthamine hydrochloride on
experimental osteoporosis in ovariectomized mice. Biol Pharm Bull.
22:920–924. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Horcajada-Molteni MN, Crespy V, Coxam V,
Davicco MJ, Rémésy C and Barlet JP: Rutin inhibits
ovariectomy-induced osteopenia in rats. J Bone Miner Res.
15:2251–2258. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Miyakoshi N, Sato K, Tamura Y, Tsuchida T,
Kudo T and Kasukawa Y: Evaluation of long-term sequential changes
in bone mass and strength following withdrawal of incadronate
disodium (YM175) in ovariectomized rats. J Orthop Sci. 6:167–176.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Glatt M, Pataki A, Evans GP, Hornby SB and
Green JR: Loss of vertebral bone and mechanical strength in
estrogen-deficient rats is prevented by long-term administration of
zoledronic acid. Osteoporos Int. 15:707–715. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Heikkinen T, Puoliväli J and Tanila H:
Effects of long-term ovariectomy and estrogen treatment on maze
learning in aged mice. Exp Gerontol. 39:1277–1283. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Weinreb M, Patael H, Preisler O and
Ben-Shemen S: Short-term healing kinetics of cortical and
cancellous bone osteopenia induced by unloading during the
reloading period in young rats. Virchows Arch. 431:449–452. 1997.
View Article : Google Scholar : PubMed/NCBI
|
